Category Archives: Pr Newswire

/C O R R E C T I O N — Menarini Silicon Biosystems/

In the news release, Menarini’s cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2024 by Menarini Silicon Biosystems over PR Newswire, we are advised by the company that the subheadline, second sentence and the second paragraph, second sentence should read “400Kb” rather than […]

JX Luxventure Signs Blockbuster USD100,000,000 (3X 2023 Revenue) Sales Agreement

HAIKOU, China, July 3, 2024 /PRNewswire/ — JX Luxventure Limited (Nasdaq: JXJT) (the “Company”), a technology company engages in integrated tourism services, including tourism, duty-free cross-border goods, and comprehensive e-commerce technology solutions, today announced that, on July 1, 2024, Jinxuan (Hainan) Holding Group Co., Ltd (“JX Hainan”), a subsidiary of the Company, entered into and executed a Cooperation […]

Mainz Biomed Provides Half Year 2024 Corporate Update

Industry Leading Clinical Data Position the Company for FDA Premarket Approval Study BERKELEY, Calif. and MAINZ, Germany, July 02, 2024 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first six months ending June 30, 2024, and […]

Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study

DALLAS, July 02, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has achieved 100% pediatric patient enrollment at burn centers for its 2024 pivotal study designed […]

Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional investor for the issuance and sale of an aggregate of 5,853,659 shares of its common stock (or common stock equivalents […]

Inspire Medical Systems, Inc. to Report Second Quarter 2024 Financial Results on August 6, 2024

MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, August 6. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business […]

Dr. Gabriele Weichert takes the helm as President of the Canadian Dermatology Association

OTTAWA, July 02, 2024 (GLOBE NEWSWIRE) — The Canadian Dermatology Association (CDA) is proud to announce the appointment of Dr. Gabriele Weichert as CDA President, effective June 28, 2024. Dr. Gabriele Weichert is the medical director at SkinCareWest, a medical and surgical Dermatology clinic in Nanaimo BC. She has been in practice for 20 years. […]

Beko achieves 44th place on TIME’s inaugural list of the world’s most sustainable companies

Ranked among the top 500 global companies leading the way in sustainability. Recognized for its commitment to eco-friendly practices and net-zero goals. Highest-ranking home appliance company on the list. ISTANBUL, July 2, 2024 /PRNewswire/ — Global household appliance manufacturer Beko has been recognized for its commitment to sustainability, securing the 44th spot on TIME Magazine […]

Pulnovo Medical Announces First Enrollment in Portugal for Global Clinical Study of PADN Technology in Treating Pulmonary Hypertension Associated with Left Heart Disease

SHANGHAI, July 2, 2024 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter clinical study exploring the percutaneous pulmonary artery denervation (PADN) treatment for pulmonary hypertension associated with left heart disease. This landmark […]

Montrose Environmental Group Releases 2023 Sustainability Report Executive Summary

LITTLE ROCK, Ark., July 2, 2024 /PRNewswire/ — Montrose Environmental Group, Inc. (“Montrose” or “the Company”) (NYSE: MEG), a high-growth global environmental solutions company, today released its 2023 Sustainability Report Executive Summary highlighting key accomplishments in the Company’s sustainability journey and celebrating innovations creating impact across the globe.   The 2023 Sustainability Report Executive Summary focuses […]